deucravacitinib,apremilast
bms,amgen
['psoriasis', 'deucrava', 'deucra']
u.s. food and drug administration approves sotyktu (deucravacitinib), oral treatment for adults with moderate-to-severe plaque psoriasis #stocksmarket #pressrelease
Stock Market News and Press Releases. #StockMarket & #Crypto